Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial

Area of Science:

• Clinical Microbiology
• Molecular Diagnostics
• Infectious Diseases

Background:

• Sepsis poses a significant threat to public health, causing high morbidity, mortality, and healthcare costs.
• Timely and accurate diagnosis of sepsis is crucial for improving patient outcomes and reducing economic burden.
• Current diagnostic methods can be time-consuming, delaying appropriate treatment.

Purpose of the Study:

• To evaluate the performance of the FilmArray blood culture identification panel for detecting sepsis pathogens and antimicrobial resistance genes.
• To compare the panel's sensitivity and specificity against standard laboratory identification techniques and molecular methods.
• To assess the panel's utility in a multi-center trial setting.

Main Methods:

• An eight-center trial was conducted using 2,207 positive aerobic blood culture samples (1,568 clinical, 639 seeded).
• The FilmArray panel, a multiplex PCR assay, was used to identify 24 etiologic agents and 3 antimicrobial resistance genes.
• Performance was compared to standard phenotypic identification and other molecular methods.

Main Results:

• The panel detected at least one organism in 88.1% of positive clinical specimens.
• Overall sensitivity for target detections exceeded 96%, with high sensitivity and specificity for antimicrobial resistance genes (mecA, vanA/B, blaKPC).
• The panel provided results in approximately one hour, demonstrating high accuracy for common sepsis pathogens.

Conclusions:

• The FilmArray blood culture identification panel is a highly sensitive and specific tool for rapid sepsis diagnosis.
• The assay significantly reduces turnaround time compared to conventional methods.
• This molecular diagnostic approach can aid in optimizing antimicrobial therapy and improving patient management for sepsis.